STIMULATION OF OSTEOBLASTIC PHENOTYPES BY STRONTIUM IN PERIOSTEAL-DERIVED CELLS

골막기원세포에서 strontium에 의한 조골세포 표현형의 활성

  • Kim, Shin-Won (Department of Oral and Maxillofacial Surgery, School of Dentistry, Pusan National University) ;
  • Kim, Uk-Kyu (Department of Oral and Maxillofacial Surgery, School of Dentistry, Pusan National University) ;
  • Park, Bong-Wook (Department of Oral and Maxillofacial Surgery, Gyeongsang National University School of Medicine and Institute of Health Sciences, Biomedical center (BK21)) ;
  • Hah, Young-Sool (Clinical Research Institute, Gyeongsang National University Hospital) ;
  • Cho, Hee-Young (Clinical Research Institute, Gyeongsang National University Hospital) ;
  • Kim, Jung-Hwan (Clinical Research Institute, Gyeongsang National University Hospital) ;
  • Kim, Deok-Ryong (Department of Biochemistry, Gyeongsang National University School of Medicine and Institute of Health Sciences, Biomedical center (BK21)) ;
  • Kim, Jong-Ryoul (Department of Oral and Maxillofacial Surgery, Onhospital) ;
  • Joo, Hyun-Ho (Department of Oral and Maxillofacial Surgery, Gyeongsang National University School of Medicine and Institute of Health Sciences, Biomedical center (BK21)) ;
  • Byun, June-Ho (Department of Oral and Maxillofacial Surgery, Gyeongsang National University School of Medicine and Institute of Health Sciences, Biomedical center (BK21))
  • 김신원 (부산대학교 치의학전문대학원 구강악안면외과) ;
  • 김욱규 (부산대학교 치의학전문대학원 구강악안면외과) ;
  • 박봉욱 (경상대학교 의학전문대학원 구강악안면외과학교실, 경상대학교 건강과학연구원, 의생명과학사업단 (BK21)) ;
  • 하영술 (경상대학교병원 임상의학연구소) ;
  • 조희영 (경상대학교병원 임상의학연구소) ;
  • 김정환 (경상대학교병원 임상의학연구소) ;
  • 김덕룡 (경상대학교 의학전문대학원 생화학교실, 경상대학교 건강과학연구원, 의생명과학사업단 (BK21)) ;
  • 김종렬 (온종합병원 구강악안면외과) ;
  • 주현호 (경상대학교 의학전문대학원 구강악안면외과학교실, 경상대학교 건강과학연구원, 의생명과학사업단 (BK21)) ;
  • 변준호 (경상대학교 의학전문대학원 구강악안면외과학교실, 경상대학교 건강과학연구원, 의생명과학사업단 (BK21))
  • Received : 2010.03.30
  • Accepted : 2010.05.06
  • Published : 2010.05.31

Abstract

This study investigated the effects of strontium on osteoblastic phenotypes of cultured human periostealderived cells. Periosteal tissues were harvested from mandible during surgical extraction of lower impacted third molar. Periosteal-derived cells were introduced into cell culture. After passage 3, the periostealderived cells were further cultured for 28 days in an osteogenic induction DMEM medium supplemented with fetal bovine serum, ascorbic acid 2-phosphate, dexamethasone and at a density of $3{\times}10^4$ cells/well in a 6-well plate. In this culture medium, strontium at different concentrations (1, 5, 10, and 100 ${\mu}g$/mL) was added. The medium was changed every 3 days during the incubation period. We examined the cellular proliferation, histochemical detection and biochemical measurements of alkaline phosphatase (ALP), the RT-PCR analysis for ALP and osteocalcin, and von Kossa staining and calcium contents in the periostealderived cells. Cell proliferation was not associated with the addition of strontium in periosteal-derived cells. The ALP activity in the periosteal-derived cells was higher in 5, 10, and 100 ${\mu}g$/ml strontium-treated cells than in untreated cells at day 14 of culture. Among the strontium-treated cells, the ALP activity was appreciably higher in 100 ${\mu}g$/ml strontium-treated cells than in 5 and 10 ${\mu}g$/ml strontium-treated cells. The levels of ALP and osteocalcin mRNA in the periosteal-derived cells was also higher in strontium-treated cells than in untreated cells at day 14 of culture. Their levels were increased in a dose-dependent manner. Von Kossa-positive mineralization nodules were strongly observed in the 1 ${\mu}g$/ml strontium-treated cells at day 21 and 28 of culture. The calcium content in the periosteal-derived cells was also higher in 1 ${\mu}g$/ml strontium-treated cells at day 28 of culture. These results suggest that low concentration of strontium stimulates the osteoblastic phenotypes of more differentiated periosteal-derived cells, whereas high concentration of strontium stimulates the osteoblastic phenotypes of less differentiated periosteal-derived cells. The effects of strontium on osteoblastic phenotypes of periosteal-derived cells appear to be associated with differentiation-extent.

Keywords

References

  1. Meunier PJ, Roux C, Seeman E et al : The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350 : 459, 2004. https://doi.org/10.1056/NEJMoa022436
  2. Reginster JY, Seeman E, De Vernejoul MC et al : Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis : Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab 90 : 2816, 2005. https://doi.org/10.1210/jc.2004-1774
  3. Lindsay R, Gallagher JC, Kleerekoper M et al : Bone response to treatment with lower doses of conjugated estrogens with and without medroxyprogesterone acetate in early postmenopausal women. Osteoporos Int 16 : 372, 2005. https://doi.org/10.1007/s00198-004-1773-4
  4. Caverzasio J : Strontium ranelate promotes osteoblastic cell replication through at least two different mechanisms. Bone 42 : 1131, 2008. https://doi.org/10.1016/j.bone.2008.02.010
  5. Chattopadhyay N, Quinn SJ, Kifor O et al : The calciumsensing receptor (CaR) is involved in strontium ranelateinduced osteoblast proliferation. Biochem Pharmacol 74 : 438, 2007. https://doi.org/10.1016/j.bcp.2007.04.020
  6. Verberckmoes SC, De Broe ME, D'Haese PC : Dosedependent effects of strontium on osteoblast function and mineralization. Kidney Int 64 : 534, 2003. https://doi.org/10.1046/j.1523-1755.2003.00123.x
  7. Zhu LL, Zaidi S, Peng Y et al : Induction of a program gene expression during osteoblast differentiation with strontium ranelate. Biochem Biophys Res Commun 355 : 307, 2007. https://doi.org/10.1016/j.bbrc.2007.01.120
  8. Canalis E, Hott M, Deloffre P et al : The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro. Bone 18 : 517, 1996. https://doi.org/10.1016/8756-3282(96)00080-4
  9. Marie PJ, Hott M, Modrowski D et al : An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res 8 : 607, 1993.
  10. Buehler J, Chappuis P, Saffar JL et al : Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis). Bone 29 : 176, 2001. https://doi.org/10.1016/S8756-3282(01)00484-7
  11. Delannoy P, Bazot D, Marie PJ : Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice. Metabolism 51 : 906, 2002. https://doi.org/10.1053/meta.2002.33360
  12. Hott M, Deloffre P, Tsouderos Y et al : S12911-2 reduces bone loss induced by short-term immobilization in rats. Bone 33 : 115, 2003. https://doi.org/10.1016/S8756-3282(03)00115-7
  13. Park BW, Byun JH, Lee SG et al : Evaluation of osteogenic activity and mineralization of cultured human periosteal-derived cells. J Kor Maxillofac Plast Reconstr Surg 28 : 511, 2006.
  14. Park BW, Byun JH, Ryu YM et al : Correlation between vascular endothelial growth factor signaling and mineralization during osteoblastic differentiation of cultured human periosteal-derived cells. J Kor Maxillofac Plast Reconstr Surg 29 : 197, 2007.
  15. Atkins GJ, Welldon KJ, Halbout P et al : Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response. Osteoporos Int 20 : 653, 2009. https://doi.org/10.1007/s00198-008-0728-6
  16. Barbara A, Delannoy P, Denis BG et al : Normal matrix mineralization induced by strontium ranelate in MC3T3- E1 osteogenic cells. Metabolism 53 : 532, 2004. https://doi.org/10.1016/j.metabol.2003.10.022